These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22553492)

  • 1. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment.
    Tarawneh R; Holtzman DM
    Cold Spring Harb Perspect Med; 2012 May; 2(5):a006148. PubMed ID: 22553492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing patient and informant ratings of depressive symptoms in various stages of Alzheimer's disease.
    Gold D; Rosowsky E; Piryatinsky I; Sinclair SJ
    Neuropsychology; 2020 Jul; 34(5):535-550. PubMed ID: 32191055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
    Göthlin M; Eckerström M; Lindwall M; Rolstad S; Eckerström C; Jonsson M; Kettunen P; Svensson J; Wallin A
    J Alzheimers Dis; 2020; 73(3):955-966. PubMed ID: 31868665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment.
    Yatawara C; Lim L; Chander R; Zhou J; Kandiah N
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of MRI for diagnosing dementia].
    Tokumaru AM
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():494-508. PubMed ID: 22787840
    [No Abstract]   [Full Text] [Related]  

  • 6. Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study.
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Am J Geriatr Psychiatry; 2021 Mar; 29(3):272-284. PubMed ID: 32863138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
    Mc Ardle R; Galna B; Donaghy P; Thomas A; Rochester L
    Alzheimers Dement; 2019 Oct; 15(10):1367-1377. PubMed ID: 31548122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.
    Seifan A; Ganzer CA; Ryon K; Lin M; Mahmudur R; Adolfo H; Shih C; Jacobs AR; Greenwald M; Isaacson RS
    Curr Aging Sci; 2019; 11(4):242-249. PubMed ID: 30845903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué-Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010783. PubMed ID: 34313331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias.
    Corey-Bloom J
    Int Psychogeriatr; 2002; 14 Suppl 1():51-75. PubMed ID: 12636180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.
    Smith CR; Cullen B; Sheridan MP; Cavanagh J; Grosset KA; Grosset DG
    Acta Neurol Scand; 2020 Jun; 141(6):500-508. PubMed ID: 32002988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy.
    Padovani A; Benussi A; Cotelli MS; Ferrari C; Cantoni V; Dell'Era V; Turrone R; Paghera B; Borroni B
    Alzheimers Res Ther; 2019 Dec; 11(1):95. PubMed ID: 31787103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.
    Keine D; Walker JQ; Kennedy BK; Sabbagh MN
    Curr Aging Sci; 2018; 11(3):173-181. PubMed ID: 30338750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.